In addition to revenue growth, HCG demonstrated robust gains across key financial indicators. For Q2, the company reported an adjusted EBITDA of Rs 1,042 million, marking a 21 per cent year-on-year increase with an EBITDA margin of 18.8 per cent
Read More
